Regorafenib for treating advanced gastrointestinal stromal tumours [ID1056]
In development
Reference number: GID-TA10089
Expected publication date:
Following the recent discussion on 28 June, the committee concluded that it needed more information from the company before it can make a decision. Given the information is related to the technical aspects of the economic analysis, we will not be issuing any documentation at this stage. The committee will consider the additional information at its meeting on Wednesday 30 August 2017 and continue its deliberations on regorafenib for gastrointestinal stromal tumours.